Skip to main content
Top
Gepubliceerd in: Quality of Life Research 3/2021

26-10-2020

Development and validation of a voice-of-the-patient measure of cognitive concerns experienced by people living with HIV

Auteurs: Sorayya Askari, Lesley K. Fellows, Marie-Josée Brouillette, Nancy E. Mayo

Gepubliceerd in: Quality of Life Research | Uitgave 3/2021

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Abstract

Purpose

People living with HIV may experience some degree of mild cognitive impairment. They are best placed to report on their cognitive symptoms, but no HIV-specific questionnaire exists to elicit these concerns. This study aimed to validate a set of items to form a measure

Methods

48 items were tested on an initial sample of 204 people with HIV. Rasch analysis was used to identify those that fit a hierarchical continuum. The hierarchy was validated on a new sample of 703 people with HIV and a sample of 484 people without HIV.

Results

18 items fit the model and formed the Communicating Cognitive Concerns Questionnaire (C3Q). The items spanned the full range of cognitive ability, distinguished between people working and not working, and correlated with other self-report outcomes such as mental health (0.56) and work productivity (0.60), although showed a low correlation with cognitive test performance.

Conclusion

The C3Q is the first questionnaire specifically developed for use among people with HIV. While not strongly associated with cognitive test performance, it reflects real-life concerns of people and is associated with mood, work, and work productivity. It is a needed step in assessing cognition in this population.
Bijlagen
Alleen toegankelijk voor geautoriseerde gebruikers
Literatuur
1.
go back to reference McArthur, J. C., et al. (2010). Human immunodeficiency virus-associated neurocognitive disorders: Mind the gap. Annals of Neurology, 67(6), 699–714.PubMed McArthur, J. C., et al. (2010). Human immunodeficiency virus-associated neurocognitive disorders: Mind the gap. Annals of Neurology, 67(6), 699–714.PubMed
2.
go back to reference Gorman, A. A., et al. (2009). Functional consequences of HIV-associated neuropsychological impairment. Neuropsychology Review, 19(2), 186–203.CrossRef Gorman, A. A., et al. (2009). Functional consequences of HIV-associated neuropsychological impairment. Neuropsychology Review, 19(2), 186–203.CrossRef
3.
go back to reference Heaton, R. K., et al. (2004). The impact of HIV-associated neuropsychological impairment on everyday functioning. Journal of the International Neuropsychological Society, 10(3), 317–331.CrossRef Heaton, R. K., et al. (2004). The impact of HIV-associated neuropsychological impairment on everyday functioning. Journal of the International Neuropsychological Society, 10(3), 317–331.CrossRef
4.
go back to reference Tozzi, V., et al. (2003). Neurocognitive performance and quality of life in patients with HIV infection. AIDS Research and Human Retroviruses, 19(8), 643–652.CrossRef Tozzi, V., et al. (2003). Neurocognitive performance and quality of life in patients with HIV infection. AIDS Research and Human Retroviruses, 19(8), 643–652.CrossRef
5.
go back to reference Simioni, S., et al. (2010). Cognitive dysfunction in HIV patients despite long-standing suppression of viremia. AIDS, 24(9), 1243–1250.CrossRef Simioni, S., et al. (2010). Cognitive dysfunction in HIV patients despite long-standing suppression of viremia. AIDS, 24(9), 1243–1250.CrossRef
6.
go back to reference Heaton, R. K., et al. (2010). HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study. Neurology, 75(23), 2087–2096.CrossRef Heaton, R. K., et al. (2010). HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study. Neurology, 75(23), 2087–2096.CrossRef
7.
go back to reference FDA, The voice of the patient: A series of reports from FDA's patient-focused drug development initiative. 2014. FDA, The voice of the patient: A series of reports from FDA's patient-focused drug development initiative. 2014.
8.
go back to reference Chelune, G. J., Heaton, R. K., & Lehman, R. A. W. (1986). Neuropsychological and personality correlates of patients’ complaints of disability. In G. Goldstein & R. E. Tarter (Eds.), Advances in clinical neuropsychology (pp. 95–126). Boston: Springer.CrossRef Chelune, G. J., Heaton, R. K., & Lehman, R. A. W. (1986). Neuropsychological and personality correlates of patients’ complaints of disability. In G. Goldstein & R. E. Tarter (Eds.), Advances in clinical neuropsychology (pp. 95–126). Boston: Springer.CrossRef
9.
go back to reference Sullivan, J., Edgeley, K., & Dehoux, E. (1990). A survey of multiple sclerosis. Part I: perceived cognitive problems and compensatory strategy used. Canadian Journal of Rehabilitation, 4, 99–105. Sullivan, J., Edgeley, K., & Dehoux, E. (1990). A survey of multiple sclerosis. Part I: perceived cognitive problems and compensatory strategy used. Canadian Journal of Rehabilitation, 4, 99–105.
10.
go back to reference Broadbent, D. E., et al. (1982). The cognitive failures questionnaire (CFQ) and its correlates. British Journal of Clinical Psychology, 21(1), 1–16.CrossRef Broadbent, D. E., et al. (1982). The cognitive failures questionnaire (CFQ) and its correlates. British Journal of Clinical Psychology, 21(1), 1–16.CrossRef
11.
go back to reference WHO, WHOQOL-BREF: introduction, administration, scoring and generic version of the assessment. 1996, WHO. WHO, WHOQOL-BREF: introduction, administration, scoring and generic version of the assessment. 1996, WHO.
12.
go back to reference Wu, A. W., et al. (1997). Evidence for reliability, validity and usefulness of the Medical Outcomes Study HIV Health Survey (MOS-HIV). Quality of Life Research, 6(6), 481–493.CrossRef Wu, A. W., et al. (1997). Evidence for reliability, validity and usefulness of the Medical Outcomes Study HIV Health Survey (MOS-HIV). Quality of Life Research, 6(6), 481–493.CrossRef
13.
go back to reference Duracinsky, M., et al. (2012). The development of PROQOL-HIV: An international instrument to assess the health-related quality of life of persons living with HIV/AIDS. Journal of Acquired Immune Deficiency Syndromes, 59(5), 498–505.CrossRef Duracinsky, M., et al. (2012). The development of PROQOL-HIV: An international instrument to assess the health-related quality of life of persons living with HIV/AIDS. Journal of Acquired Immune Deficiency Syndromes, 59(5), 498–505.CrossRef
14.
go back to reference FDA, Guidance for Industry: Patient-Reported Outcome Measures: Use in medical product development to support labeling claims. 2009. FDA, Guidance for Industry: Patient-Reported Outcome Measures: Use in medical product development to support labeling claims. 2009.
15.
go back to reference Askari, S., et al. (2018). Development of an item pool reflecting cognitive concerns expressed by people with HIV. American Journal of Occupational Therapy., 72(2), 1–9.CrossRef Askari, S., et al. (2018). Development of an item pool reflecting cognitive concerns expressed by people with HIV. American Journal of Occupational Therapy., 72(2), 1–9.CrossRef
16.
go back to reference Mayo, N. E., et al. (2016). Understanding and optimizing brain health in HIV now: Protocol for a longitudinal cohort study with multiple randomized controlled trials. BMC Neurology, 16, 8–8.CrossRef Mayo, N. E., et al. (2016). Understanding and optimizing brain health in HIV now: Protocol for a longitudinal cohort study with multiple randomized controlled trials. BMC Neurology, 16, 8–8.CrossRef
17.
go back to reference Tennant, A., & Conaghan, P. G. (2007). The Rasch measurement model in rheumatology: what is it and why use it? When should it be applied, and what should one look for in a Rasch paper? Arthritis and Rheumatism, 57(8), 1358–1362.CrossRef Tennant, A., & Conaghan, P. G. (2007). The Rasch measurement model in rheumatology: what is it and why use it? When should it be applied, and what should one look for in a Rasch paper? Arthritis and Rheumatism, 57(8), 1358–1362.CrossRef
18.
go back to reference Al Zoubi, F., et al. (2018). Applying modern measurement approaches to constructs relevant to evidence-based practice among Canadian physical and occupational therapists. Implementation Science, 13(1), 152.CrossRef Al Zoubi, F., et al. (2018). Applying modern measurement approaches to constructs relevant to evidence-based practice among Canadian physical and occupational therapists. Implementation Science, 13(1), 152.CrossRef
19.
go back to reference Linacre, J. (1994). Sample size and item calibration stability. Rasch Measurement Transactions, 7(4), 328. Linacre, J. (1994). Sample size and item calibration stability. Rasch Measurement Transactions, 7(4), 328.
20.
go back to reference Brouillette, M. J., et al. (2015). Quantifying cognition at the bedside: A novel approach combining cognitive symptoms and signs in HIV. BMC Neurology, 15, 224.CrossRef Brouillette, M. J., et al. (2015). Quantifying cognition at the bedside: A novel approach combining cognitive symptoms and signs in HIV. BMC Neurology, 15, 224.CrossRef
21.
go back to reference Koski, L., et al. (2011). Computerized testing augments pencil-and-paper tasks in measuring HIV-associated mild cognitive impairment(*). HIV Medications, 12(8), 472–480.CrossRef Koski, L., et al. (2011). Computerized testing augments pencil-and-paper tasks in measuring HIV-associated mild cognitive impairment(*). HIV Medications, 12(8), 472–480.CrossRef
22.
go back to reference Hays, R. D., Sherbourne, C. D., & Mazel, R. M. (1993). The RAND 36-item health survey 1.0. Health Economy, 2(3), 217–27.CrossRef Hays, R. D., Sherbourne, C. D., & Mazel, R. M. (1993). The RAND 36-item health survey 1.0. Health Economy, 2(3), 217–27.CrossRef
23.
go back to reference Turpin, R. S., et al. (2004). Reliability and validity of the Stanford Presenteeism Scale. Journal of Occupational and Environmental Medicine, 46(11), 1123–1133.CrossRef Turpin, R. S., et al. (2004). Reliability and validity of the Stanford Presenteeism Scale. Journal of Occupational and Environmental Medicine, 46(11), 1123–1133.CrossRef
24.
go back to reference Lam, R. W., et al. (2018). Psychometric validation of the Perceived Deficits Questionnaire-Depression (PDQ-D) instrument in US and UK respondents with major depressive disorder. Neuropsychiatric Disease and Treatment, 14, 2861–2877.CrossRef Lam, R. W., et al. (2018). Psychometric validation of the Perceived Deficits Questionnaire-Depression (PDQ-D) instrument in US and UK respondents with major depressive disorder. Neuropsychiatric Disease and Treatment, 14, 2861–2877.CrossRef
25.
go back to reference VanderZee, K. I., Sanderman, R., & Heyink, J. (1996). A comparison of two multidimensional measures of health status: The Nottingham Health Profile and the RAND 36-Item Health Survey 1.0. Quality of Life Research, 5(1), 165–174.CrossRef VanderZee, K. I., Sanderman, R., & Heyink, J. (1996). A comparison of two multidimensional measures of health status: The Nottingham Health Profile and the RAND 36-Item Health Survey 1.0. Quality of Life Research, 5(1), 165–174.CrossRef
26.
go back to reference Terwee, C. B., et al. (2007). Quality criteria were proposed for measurement properties of health status questionnaires. Journal of Clinical Epidemiology, 60(1), 34–42.CrossRef Terwee, C. B., et al. (2007). Quality criteria were proposed for measurement properties of health status questionnaires. Journal of Clinical Epidemiology, 60(1), 34–42.CrossRef
27.
go back to reference Norman, G. R., Sloan, J. A., & Wyrwich, K. W. (2004). The truly remarkable universality of half a standard deviation: Confirmation through another look. Expert Review of Pharmacoeconomics & Outcomes Research, 4(5), 581–585.CrossRef Norman, G. R., Sloan, J. A., & Wyrwich, K. W. (2004). The truly remarkable universality of half a standard deviation: Confirmation through another look. Expert Review of Pharmacoeconomics & Outcomes Research, 4(5), 581–585.CrossRef
28.
go back to reference Mayo, N. E., et al. (2017). In support of an individualized approach to assessing quality of life: Comparison between Patient Generated Index and standardized measures across four health conditions. Quality of Life Research, 26(3), 601–609.CrossRef Mayo, N. E., et al. (2017). In support of an individualized approach to assessing quality of life: Comparison between Patient Generated Index and standardized measures across four health conditions. Quality of Life Research, 26(3), 601–609.CrossRef
29.
go back to reference Chaytor, N., & Schmitter-Edgecombe, M. (2003). The ecological validity of neuropsychological tests: A review of the literature on everyday cognitive skills. Neuropsychology Review, 13(4), 181–197.CrossRef Chaytor, N., & Schmitter-Edgecombe, M. (2003). The ecological validity of neuropsychological tests: A review of the literature on everyday cognitive skills. Neuropsychology Review, 13(4), 181–197.CrossRef
30.
go back to reference Baars, B. J., & Gage, N. M. (2010). Cognition, brain, and consciousness: Introduction to cognitive neuroscience (2nd ed.). San Diego: Elsevier Academic Press. Baars, B. J., & Gage, N. M. (2010). Cognition, brain, and consciousness: Introduction to cognitive neuroscience (2nd ed.). San Diego: Elsevier Academic Press.
31.
go back to reference Mayo, N. E. (2015). Dictionary of quality of life and health outcomes measurement. ISOQOL. Mayo, N. E. (2015). Dictionary of quality of life and health outcomes measurement. ISOQOL.
32.
go back to reference Morgan, S. J., et al. (2016). Self-reported cognitive concerns in people with lower limb loss. Archives of physical medicine and rehabilitation, 97(6), 912–918.CrossRef Morgan, S. J., et al. (2016). Self-reported cognitive concerns in people with lower limb loss. Archives of physical medicine and rehabilitation, 97(6), 912–918.CrossRef
33.
go back to reference Hobart, J., et al. (2013). Putting the Alzheimer’s cognitive test to the test II: Rasch Measurement Theory. Alzheimers Dement, 9(1 Suppl), S10-20.CrossRef Hobart, J., et al. (2013). Putting the Alzheimer’s cognitive test to the test II: Rasch Measurement Theory. Alzheimers Dement, 9(1 Suppl), S10-20.CrossRef
34.
go back to reference Nasreddine, Z. S., et al. (2005). The montreal cognitive assessment, MoCA: A brief screening tool for mild cognitive impairment. Journal of the American Geriatrics Society, 53(4), 695–699.CrossRef Nasreddine, Z. S., et al. (2005). The montreal cognitive assessment, MoCA: A brief screening tool for mild cognitive impairment. Journal of the American Geriatrics Society, 53(4), 695–699.CrossRef
35.
go back to reference Dang, J., King, K. M., & Inzlicht, M. (2020). Why are self-report and behavioral measures weakly correlated? Trends in Cognitive Sciences, 24(4), 267–269.CrossRef Dang, J., King, K. M., & Inzlicht, M. (2020). Why are self-report and behavioral measures weakly correlated? Trends in Cognitive Sciences, 24(4), 267–269.CrossRef
36.
go back to reference Kelly, M. E., et al. (2017). The impact of social activities, social networks, social support and social relationships on the cognitive functioning of healthy older adults: A systematic review. Syst Rev, 6(1), 259.CrossRef Kelly, M. E., et al. (2017). The impact of social activities, social networks, social support and social relationships on the cognitive functioning of healthy older adults: A systematic review. Syst Rev, 6(1), 259.CrossRef
37.
go back to reference Kelly, M. E., et al. (2014). The impact of exercise on the cognitive functioning of healthy older adults: A systematic review and meta-analysis. Ageing Research Reviews, 16, 12–31.CrossRef Kelly, M. E., et al. (2014). The impact of exercise on the cognitive functioning of healthy older adults: A systematic review and meta-analysis. Ageing Research Reviews, 16, 12–31.CrossRef
38.
go back to reference Loughrey, D. G., et al. (2017). The impact of the Mediterranean diet on the cognitive functioning of healthy older adults: A systematic review and meta-analysis. Advances in Nutrition, 8(4), 571–586.PubMedPubMedCentral Loughrey, D. G., et al. (2017). The impact of the Mediterranean diet on the cognitive functioning of healthy older adults: A systematic review and meta-analysis. Advances in Nutrition, 8(4), 571–586.PubMedPubMedCentral
39.
go back to reference Lam, A., et al. (2019). HIV-related stigma affects cognition in older men living with HIV. Journal of Acquired Immune Deficiency Syndromes, 80(2), 198–204.CrossRef Lam, A., et al. (2019). HIV-related stigma affects cognition in older men living with HIV. Journal of Acquired Immune Deficiency Syndromes, 80(2), 198–204.CrossRef
Metagegevens
Titel
Development and validation of a voice-of-the-patient measure of cognitive concerns experienced by people living with HIV
Auteurs
Sorayya Askari
Lesley K. Fellows
Marie-Josée Brouillette
Nancy E. Mayo
Publicatiedatum
26-10-2020
Uitgeverij
Springer International Publishing
Gepubliceerd in
Quality of Life Research / Uitgave 3/2021
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-020-02679-z

Andere artikelen Uitgave 3/2021

Quality of Life Research 3/2021 Naar de uitgave